WE ARE INNOVATORS
Rooted in excellence. Leaders in innovation.
Leading the future of cannabis
From cutting-edge R&D to a commitment to efficiency and sustainability, we drive innovation to create high-quality cannabis products while ensuring long-term industry leadership and business growth.
From Seed to Shelf
We control every step—from cultivation to distribution—to ensure quality, consistency, and faster innovation, delivering superior products to consumers worldwide.
Consumer-Driven Innovation
Rooted in consumer insights, our brands deliver award-winning products that stand out in the cannabis market and attract new consumers.
Less Waste, More Profit
By reducing waste and reusing materials, we cut costs and maximize value, creating a more sustainable and profitable production process.
Edison Sonics Gummies
The launch of Edison Sonics Gummies, available in bold flavours like Kiwi Berry Burst and Red Razz Chiller, marks a significant milestone for the Edison brand, renowned for first-to-market innovations like JOLTS.
Powered by insights from one of the largest pharmacokinetic studies in the cannabis industry, FAST™ is revolutionizing edibles, offering a scientifically advanced, consumer-focused product that reflects Organigram’s commitment to quality and research.
Consumer Innovations
Product Development Collaboration with BAT
On March 11, 2021, the Company announced a $221 million strategic investment from a wholly-owned subsidiary of BAT, which subscribed for approximately 58.3 million Common Shares of the Company at $3.792 per common share, which represented a 19.9% equity interest in the Company on a post-transaction basis at the time of announcement.
Concurrent with the investment, Organigram Inc. and BAT also entered into a Product Development Collaboration Agreement (the “PDC Agreement”) pursuant to which a “Center of Excellence” has been established to focus on developing the next generation of cannabis products.
An Innovation Collaboration
Our collaboration with British American Tobacco (BAT) is a driving force for cannabis innovation. At the core of this alliance is the Product Development Center (PDC), a cutting-edge hub dedicated to advancing cannabis science and product development.
The PDC is pioneering breakthrough technologies, such as our clinically validated nanoemulsion technology, designed to enhance bioavailability, deliver predictable effects, and create differentiated consumer experiences.
Leveraging expertise in extraction, compliance, and analytical methods, the PDC fosters a culture of innovation that sets new industry benchmarks.
This collaboration underscores our commitment to shaping the future of cannabis—developing products that stand out globally for their efficacy, differentiation, and consumer appeal.
Nano Clinical Study
FAST
™
Organigram’s groundbreaking FAST™ Nanoemulsion Technology is setting a new standard in cannabis innovation. This patent-pending delivery system, first showcased in Edison Sonics Gummies, is clinically proven to deliver up to ~50% faster onset and nearly double the cannabinoid delivery at peak effect compared to traditional edibles, according to preliminary results of an extensive pharmacokinetic study.*
FAST™ works by breaking cannabinoids into tiny, highly absorbable particles, improving bioavailability and enhancing the overall consumer experience.
*Preliminary results released August 07, 2024, full results pending.